Literature DB >> 19114094

Preparation, pharmacokinetics and tissue distribution of micelles made of reverse thermo-responsive polymers.

Xingguo Yang1, Lingbing Li, Yuexia Wang, Yebang Tan.   

Abstract

New reverse thermo-responsive polymers, poly(ethylene oxide)-poly(propylene oxide) multiblock copolymers (poly(ether-carbonate)s) were synthesized. The micelles made of new reverse thermo-responsive polymers were also prepared loaded with the poorly soluble anticancer drug, hydroxycamptothecin (HCPT). The structure characterization of poly(ether-carbonate)s was determined by (1)H NMR and FT-IR analysis. The critical micelle concentration (CMC), critical micelle temperature (CMT), size distribution and drug release in vitro were determined. The pharmacokinetics and tissue distribution in vivo for novel copolymer micelles were studied. The experimental results showed that the micelles was spherical in appearance and dispersed well. The process of HCPT release from micelles in vitro was composed of two steps, abrupt release and sustained release. After i.v. administration (2h), the drug concentration of poly(ether-carbonate) micelles group in liver in mice was 3.46microg/g, while that of HCPT injection group was 0.401microg/g. Compared with HCPT injection, the elimination half-life of poly(ether-carbonate) micelles group was prolonged remarkably from 1.3 to 12.5h. The poly(ether-carbonate) micelles showed a combination of liver targeting and sustained drug release in experiments on animals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19114094     DOI: 10.1016/j.ijpharm.2008.11.028

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

Review 1.  Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.

Authors:  Ruchit Trivedi; Uday B Kompella
Journal:  Nanomedicine (Lond)       Date:  2010-04       Impact factor: 5.307

Review 2.  Nanoparticle characterization: state of the art, challenges, and emerging technologies.

Authors:  Eun Jung Cho; Hillary Holback; Karen C Liu; Sara A Abouelmagd; Joonyoung Park; Yoon Yeo
Journal:  Mol Pharm       Date:  2013-03-21       Impact factor: 4.939

3.  Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.

Authors:  Qingyong Li; Chen Liu; Xiuhua Zhao; Yuangang Zu; Ying Wang; Baoyou Zhang; Dongmei Zhao; Qi Zhao; Lin Su; Yang Gao; Baihe Sun
Journal:  Int J Nanomedicine       Date:  2011-02-20

4.  10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG1000-HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy.

Authors:  Linjie Yang; Jingyi Hong; Jing Di; Yifei Guo; Meihua Han; Meifeng Liu; Xiangtao Wang
Journal:  Int J Nanomedicine       Date:  2017-05-12

5.  Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier.

Authors:  Xin Meng; Jiansheng Liu; Xiangrong Yu; Jiajia Li; Xiaotong Lu; Teng Shen
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

6.  Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers.

Authors:  Arjun Patra; Swaha Satpathy; Muhammad Delwar Hussain; Anitha K Shenoy; Jason A Bush; Mohsin Kazi
Journal:  Int J Nanomedicine       Date:  2018-05-16

7.  Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.

Authors:  Yuangang Zu; Li Meng; Xiuhua Zhao; Yunlong Ge; Xinyang Yu; Yin Zhang; Yiping Deng
Journal:  Int J Nanomedicine       Date:  2013-03-27

8.  A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.

Authors:  Xiaofeng Yang; Yingying Liu; Yanna Zhao; Meihua Han; Yifei Guo; Haixue Kuang; Xiangtao Wang
Journal:  Int J Nanomedicine       Date:  2016-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.